Close

Antiestrogen Supplements Might Reduce Melanoma Risk

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

China Takes Decision on Medical Device...

China has hit back against certain EU restrictions that...

BD Commits Expanding the Prefilled Flush...

Beckton Dickinson – BD is investing over $35mn in...

MHRA Wants Fast Patient Access to...

The medicines and healthcare products regulatory agency – MHRA...

Portable Digital Radiography for Hospitals, Ambulatory...

FUJIFILM Healthcare Americas Corporation, which happens to be a...
According to an investigation published in Cancer Prevention Research, a journal of the American Association for Cancer Research, antiestrogen supplements may lower the risk of women with breast cancer developing melanoma. The Swiss Research Foundation against Cancer, a nonprofit group, funded the investigation. 
Data from 7,360 women who had breast cancer between 1980 and 2005 was examined by the team led by Dr. Christine Bouchardy, a professor at the University of Geneva and head of the Geneva Cancer Registry. 54% of the 7,360 women received antiestrogen therapy. 
The women were followed until 2008, during the follow-up period the investigators documented 34 cases of melanoma. The team discovered that the risk for developing melanoma was 60% higher among women who did not receive antiestrogen therapy than those who received it. 
As more focus is placed on the role estrogen plays in breast cancer, investigators are starting to wonder its role in other cancers. Bouchardy explains: "These data reinforce the hypothesis that estrogens play a role in melanoma occurrence." 
According to Bouchardy, this may be because estrogens are linked to raised levels of melanin and melanocytes production in human skin, which have been connected with early-stage melanoma. Although, Bouchardy cautioned against extensive antiestrogen supplementation to inhibit melanoma in the general population. 

Latest stories

Related stories

China Takes Decision on Medical Device Contracts for the EU

China has hit back against certain EU restrictions that...

BD Commits Expanding the Prefilled Flush Syringes in the US

Beckton Dickinson – BD is investing over $35mn in...

MHRA Wants Fast Patient Access to Innovative Medical Devices

The medicines and healthcare products regulatory agency – MHRA...

Portable Digital Radiography for Hospitals, Ambulatory Units

FUJIFILM Healthcare Americas Corporation, which happens to be a...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back